Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

NCT05272865 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea Post Chemotherapy
Vomiting
Cancer Pain
Cancer Related Pain
Neoplasms

Interventions

DRUG: Pharmacokinetic and pharmacodynamic profile of THC oral formulations with Dronabinol as comparator

Sponsor

LaSanta S A S